Jane Wasman

Insider Reports History

Entity
Individual
Location
C/O Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY
Signature
/s/ Raymond Furey (Attorney-in-Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Wasman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC Director Common Stock 100K $114K $1.14 May 25, 2024 Direct
SELLAS Life Sciences Group, Inc. Director Common Stock 10.4K $65K $6.25 Jan 22, 2024 Direct
ATHERSYS, INC / NEW Director Common Stock 35.1K $879 $0.03 Jan 9, 2023 Direct
ATHERSYS, INC / NEW Director Stock Option (right to purchase) 64.1K Sep 16, 2022 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 30K May 25, 2024 Direct
SELLAS Life Sciences Group, Inc. Director Stock Option (Right to Buy) 10K Jan 22, 2024 Direct

Insider Reports Filed by Jane Wasman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RIGL RIGEL PHARMACEUTICALS INC May 25, 2024 2 $0 4 May 29, 2024 Director
SLS SELLAS Life Sciences Group, Inc. Jan 22, 2024 2 $0 4 Jan 25, 2024 Director
RIGL RIGEL PHARMACEUTICALS INC May 26, 2023 2 $0 4 Jul 12, 2023 Director
SLS SELLAS Life Sciences Group, Inc. Feb 2, 2023 2 $0 4 Feb 3, 2023 Director
ATHX ATHERSYS, INC / NEW Jan 9, 2023 1 $0 4 Jan 11, 2023 Director
ATHX ATHERSYS, INC / NEW Sep 16, 2022 2 $0 4 Sep 20, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 20, 2022 2 $0 4 May 23, 2022 Director
SLS SELLAS Life Sciences Group, Inc. Jan 31, 2022 2 $0 4 Feb 1, 2022 Director
ATHX ATHERSYS, INC / NEW Jun 15, 2021 1 $0 4 Jun 15, 2021 Director
RIGL RIGEL PHARMACEUTICALS INC May 19, 2021 2 $0 4 May 21, 2021 Director